Literature DB >> 26499513

High Frequency of Detection by PCR of Viral Nucleic Acid in The Blood of Infants Presenting with Clinical Myocarditis.

Kathleen E Simpson1, Gregory A Storch2, Caroline K Lee2, Kent E Ward3, Saar Danon4, Catherine M Simon5, Jeffrey W Delaney6, Alan Tong7, Charles E Canter2.   

Abstract

Specific viruses are associated with pediatric myocarditis, but the prevalence of viral DNAemia detected by blood polymerase chain reaction (PCR) is unknown. We evaluated the prevalence of known cardiotropic viruses (enterovirus, adenovirus, human herpesvirus 6, and parvovirus B19) in children with clinical myocarditis (n = 21). Results were compared to pediatric controls with similar viral PCR testing. The majority of positive PCR (89 %) was noted in children ≤12 months of age at diagnosis compared to older children. Infant myocarditis patients (8/10) had increased the prevalence of PCR positivity compared to infant pediatric controls (4/114) (p < 0.0001). Other than age, patient characteristics at diagnosis were similar between PCR-positive and PCR-negative patients. Both PCR-negative myocarditis infants had clinical recovery at follow-up. Of the PCR-positive myocarditis infants, 4 had clinical recovery, 2 developed chronic cardiomyopathy, 1 underwent heart transplant, and 1 died. Infants with clinical myocarditis have a high rate of blood viral positivity, which is higher compared to older children with myocarditis and healthy infant controls. Age-related differences in PCR positivity may be due to differences in host and/or virus characteristics. Our findings suggest that viral blood PCR may be a useful diagnostic tool and identify patients who would potentially benefit from virus-specific therapy.

Entities:  

Keywords:  DNAemia; Myocarditis; Pediatric cardiology

Mesh:

Substances:

Year:  2015        PMID: 26499513      PMCID: PMC4775434          DOI: 10.1007/s00246-015-1290-6

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  17 in total

1.  Clinical features and outcomes of childhood dilated cardiomyopathy: results from a national population-based study.

Authors:  Piers E F Daubeney; Alan W Nugent; Patty Chondros; John B Carlin; Steven D Colan; Michael Cheung; Andrew M Davis; C W Chow; Robert G Weintraub
Journal:  Circulation       Date:  2006-11-20       Impact factor: 29.690

2.  Development of CMX001 (Brincidofovir) for the treatment of serious diseases or conditions caused by dsDNA viruses.

Authors:  Diana F Florescu; Megan A Keck
Journal:  Expert Rev Anti Infect Ther       Date:  2014-08-13       Impact factor: 5.091

3.  Incidence, causes, and outcomes of dilated cardiomyopathy in children.

Authors:  Jeffrey A Towbin; April M Lowe; Steven D Colan; Lynn A Sleeper; E John Orav; Sarah Clunie; Jane Messere; Gerald F Cox; Paul R Lurie; Daphne Hsu; Charles Canter; James D Wilkinson; Steven E Lipshultz
Journal:  JAMA       Date:  2006-10-18       Impact factor: 56.272

4.  Antiviral activity of coxsackievirus B3 3C protease inhibitor in experimental murine myocarditis.

Authors:  Soo-Hyeon Yun; Won Gil Lee; Yong-Chul Kim; Eun-Seon Ju; Byung-Kwan Lim; Jin-Oh Choi; Duk-Kyung Kim; Eun-Seok Jeon
Journal:  J Infect Dis       Date:  2011-12-29       Impact factor: 5.226

5.  Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients.

Authors:  Diana F Florescu; Steven A Pergam; Michael N Neely; Fang Qiu; Christine Johnston; SingSing Way; Jane Sande; Deborah A Lewinsohn; Judith A Guzman-Cottrill; Michael L Graham; Genovefa Papanicolaou; Joanne Kurtzberg; Joseph Rigdon; Wendy Painter; Herve Mommeja-Marin; Randall Lanier; Maggie Anderson; Charles van der Horst
Journal:  Biol Blood Marrow Transplant       Date:  2011-09-29       Impact factor: 5.742

6.  Activity of pleconaril against enteroviruses.

Authors:  D C Pevear; T M Tull; M E Seipel; J M Groarke
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

7.  Soluble coxsackievirus B3 3C protease inhibitor prevents cardiomyopathy in an experimental chronic myocarditis murine model.

Authors:  Byung-Kwan Lim; Soo-Hyeon Yun; Eun-Seon Ju; Bo-Kyoung Kim; You-Jung Lee; Dong-Kyeom Yoo; Young-Chul Kim; Eun-Seok Jeon
Journal:  Virus Res       Date:  2014-12-05       Impact factor: 3.303

Review 8.  Myocarditis.

Authors:  Leslie T Cooper
Journal:  N Engl J Med       Date:  2009-04-09       Impact factor: 91.245

9.  Detection of viruses in young children with fever without an apparent source.

Authors:  Joshua M Colvin; Jared T Muenzer; David M Jaffe; Avraham Smason; Elena Deych; William D Shannon; Max Q Arens; Richard S Buller; Wai-Ming Lee; Erica J Sodergren Weinstock; George M Weinstock; Gregory A Storch
Journal:  Pediatrics       Date:  2012-11-05       Impact factor: 7.124

10.  New-onset heart failure due to heart muscle disease in childhood: a prospective study in the United kingdom and Ireland.

Authors:  Rachel E Andrews; Matthew J Fenton; Deborah A Ridout; Michael Burch
Journal:  Circulation       Date:  2007-12-17       Impact factor: 29.690

View more
  9 in total

1.  Clinical Relevance of Detection of HHV-6 by PCR DNA Test in the Blood for Diagnosing Myocarditis.

Authors:  Bibhuti B Das; Bhupesh K Prusty
Journal:  Pediatr Cardiol       Date:  2016-01-06       Impact factor: 1.655

2.  MicroRNA-381 protects myocardial cell function in children and mice with viral myocarditis via targeting cyclooxygenase-2 expression.

Authors:  Yong Zhang; Lingli Sun; Hui Sun; Zhongqin Yu; Xia Liu; Xia Luo; Cuifang Li; Dongming Sun; Tao Li
Journal:  Exp Ther Med       Date:  2018-04-20       Impact factor: 2.447

Review 3.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

4.  Parvovirus B19 myocarditis in children: a diagnostic and therapeutic approach.

Authors:  Roger Esmel-Vilomara; Paola Dolader; Jaume Izquierdo-Blasco; Joan Balcells; Moisés Sorlí; Fuensanta Escudero; Elena Vera; Ferran Gran
Journal:  Eur J Pediatr       Date:  2022-02-09       Impact factor: 3.183

5.  Analyses of Tissue Culture Adaptation of Human Herpesvirus-6A by Whole Genome Deep Sequencing Redefines the Reference Sequence and Identifies Virus Entry Complex Changes.

Authors:  Joshua G Tweedy; Eric Escriva; Maya Topf; Ursula A Gompels
Journal:  Viruses       Date:  2017-12-31       Impact factor: 5.048

Review 6.  Human herpesvirus 6-induced inflammatory cardiomyopathy in immunocompetent children.

Authors:  Surabhi Reddy; Eva Eliassen; Gerhard R Krueger; Bibhuti B Das
Journal:  Ann Pediatr Cardiol       Date:  2017 Sep-Dec

7.  Pediatric Cardiology: Advances Over the Past 2 Years and Future Prospects.

Authors:  Ya-Qi Li; Qing-You Zhang; Hong-Fang Jin; Jun-Bao Du
Journal:  Chin Med J (Engl)       Date:  2017-12-05       Impact factor: 2.628

Review 8.  Recent Advances in Replication and Infection of Human Parvovirus B19.

Authors:  Safder S Ganaie; Jianming Qiu
Journal:  Front Cell Infect Microbiol       Date:  2018-06-05       Impact factor: 5.293

9.  Multisystem Involvement Induced by Human Parvovirus B19 Infection in a Non-immunosuppressed Adult: A Case Report.

Authors:  Qihang Zou; Peisong Chen; Jiaxin Chen; Dingbang Chen; Han Xia; Ling Chen; Huiyu Feng; Li Feng
Journal:  Front Med (Lausanne)       Date:  2022-04-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.